Building Lasting Relationships
Kineticos partners with companies to help them grow and develop—early funding is just the beginning.
We focus on companies striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. We seek innovative founders and companies targeting significant, unmet medical needs, with a focus on cell and gene therapy, oncology, oncology, neurosciences, rare diseases, and antimicrobial resistance.
Kineticos possesses a long history of operating, consulting, and investing in contract development and manufacturing organizations (CDMOs), equipment, and other enabling technologies.Learn More
Kineticos partners and invests in both biotech and medtech companies striving to disrupt how drugs are developed and patients are treated across oncology, neurosciences, and rare diseases.Learn More
Kineticos provides more than capital; we leverage our operator, scientific, and consultant expertise to help drive portfolio company strategy and growth. Our partnership approach delivers meaningful outcomes to patients, portfolio companies, and investors.
Kineticos seeks to partner and invest with companies at founding through their growth stage positioned to solve these service gaps and provide solutions to the advancing biologic sector.